YAP1 and Obesity: Obesity and insulin resistance are also important risk factors for the development of endometrial cancer where knockdown of YAP/TAZ has been shown to inhibit insulin signalling via phosphorylation of IRS1/2, a mediator of insulin and IGF-1 signalling in endometrial cell lines [92].